Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Coherus Biosciences (CHRS) Q1 2024 Earnings
CHRS
+3.11%
9
May
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.71
-0.54
-0.37
-0.21
Details
Expected EPS
-0.24
Actual EPS
-0.32
Surprise EPS
-0.08
Surprise Percent
+33.33%
Description
Coherus Biosciences (CHRS) has reported earnings of -0.32 per share for Q1 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login